Skip to main content

Peer Review reports

From: MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel

Original Submission
21 Jun 2017 Submitted Original manuscript
23 Jul 2017 Reviewed Reviewer Report - Hongtao Bi
26 Jul 2017 Reviewed Reviewer Report - Michał Bijak
22 Aug 2017 Author responded Author comments - Jihye Hwang
Resubmission - Version 2
22 Aug 2017 Submitted Manuscript version 2
5 Sep 2017 Reviewed Reviewer Report - Hongtao Bi
12 Sep 2017 Reviewed Reviewer Report - Michał Bijak
14 Sep 2017 Author responded Author comments - Jihye Hwang
Resubmission - Version 3
14 Sep 2017 Submitted Manuscript version 3
21 Nov 2017 Author responded Author comments - Jihye Hwang
Resubmission - Version 4
21 Nov 2017 Submitted Manuscript version 4
23 Nov 2017 Author responded Author comments - Jihye Hwang
Resubmission - Version 5
23 Nov 2017 Submitted Manuscript version 5
Publishing
28 Nov 2017 Editorially accepted
15 Dec 2017 Article published 10.1186/s12906-017-2036-1

You can find further information about peer review here.

Back to article page